bioio
Founded 2019 · 4 employees on LinkedIn · 3 known investors
BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.
Founders & leadership
bioio was founded in 2019 by Dr. Peterson.
DP
Dr. Peterson
Investors · 3
Competitors · 6
by search overlap
iBio15 shared keywordsiBio discovers antibody-based medicines for obesity and cardiometabolic disease, using an AI-assisted platform to design antibodies against hard-to-drug targets. The company operates in the biotech and drug discovery space.
bio11 shared keywordsThe Biotechnology Innovation Organization (BIO) is an advocacy organization representing biotech companies, industry leaders, and state biotech associations across the United States and more than 35 countries. It provides members with policy advocacy, cost-saving programs, educational webinars, and organizes the BIO International Convention and other industry conferences.
Bridgebio7 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
Percipio5 shared keywordsPercipio Health helps independent primary care practices claim Advanced Primary Care Management (APCM) reimbursements from Medicare that most practices do not yet operationalize. The company focuses on capturing unclaimed revenue for small independent primary care physician groups.
Indiebio5 shared keywordsIndieBio was a startup accelerator and pre-seed investment program launched by SOSV in San Francisco in 2015, providing on-site bio-labs and funding to science founders across biotech, food, agriculture, industrial decarbonization, AI, therapeutics, and diagnostics. As of 2026 the program was rebranded to SOSV NY and SOSV SF, expanding its focus from bio to broader deep tech.
BodyBio5 shared keywordsBodyBio is a third-generation family business that develops and manufactures science-backed dietary supplements and vitamins, including phosphatidylcholine (PC), butyrate, and detox products, aimed at cellular health and wellness. Products are made at the company's in-house facility with third-party testing.
Companies competing with bioio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does bioio do?
- BIOIO develops a genetics-based platform for elucidating drug mechanisms of action, combining decades of research in pharmacology with big data and automation to accelerate drug discovery and development. The company serves pharmaceutical and biotech organizations seeking to understand how drugs work.
- Who founded bioio?
- bioio was founded by Dr. Peterson in 2019.
- Who are bioio's investors?
- bioio's investors include BioGenerator Ventures, Missouri Technology Corporation, quadraScope Venture Fund.